FDA Inspection 1327552 — Neuromedex GmbH
The FDA completed an inspection of Neuromedex GmbH on May 21, 2026 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 21, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Hamburg (Germany)